STACY GEMBERLING: Open Payments
NPI 1871828905 · MIDDLEBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 110 payments from 26 companies in 2025. Trend: 2023 $1,865 · 2024 $1,639 · 2025 $1,905
Food & beverage: $1,860Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $387 |
| AstraZeneca Pharmaceuticals LP | 11 | $265 |
| ABBVIE INC. | 16 | $208 |
| Amgen Inc. | 18 | $158 |
| Lilly USA, LLC | 7 | $142 |
| Exact Sciences Corporation | 5 | $116 |
| GlaxoSmithKline, LLC. | 6 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| Dexcom, Inc. | 3 | $65 |
| Ardelyx, Inc. | 1 | $33 |
Products named: Ozempic, VRAYLAR, BREZTRI, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across PA — which companies pay providers there.
